MktsMarkets

Olema Pharmaceuticals, Inc.
NASDAQ: OLMAKey statistics
OLMA News
Stories mentioning OLMA from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 49,232 | 43,220 | 39,951 | 43,902 | 30,624 | 32,299 | 33,226 | 29,109 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 57,986 | 50,084 | 45,877 | 47,864 | 34,873 | 36,768 | 37,621 | 33,530 |
| Operating Income (Loss) | (57,986) | (50,084) | (45,877) | (47,864) | (34,873) | (36,768) | (37,621) | (33,530) |
| Interest Income | 4,776 | 4,010 | 3,648 | 4,042 | 4,524 | 3,294 | 2,928 | 3,108 |
| Interest Expense | ||||||||
| Other Expense | 121.00 | 13.00 | 12.00 | 38.00 | (40.00) | (93.00) | 138.00 | 40.00 |
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (53,089) | (46,061) | (42,217) | (43,784) | (30,389) | (33,567) | (34,555) | (30,382) |
| Earnings Per Share (Basic) | (0.52) | (0.53) | (0.49) | (0.51) | (0.36) | (0.57) | (0.60) | (0.54) |
| Earnings Per Share (Diluted) | (0.52) | (0.53) | (0.49) | (0.51) | (0.36) | (0.57) | (0.60) | (0.54) |
| Weighted Average Shares Outstanding (Basic) | 102,800 | 87,006 | 85,732 | 85,497 | 85,426 | 58,744 | 57,263 | 56,282 |
| Weighted Average Shares Outstanding (Diluted) | 102,800 | 87,006 | 85,732 | 85,497 | 85,426 | 58,744 | 57,263 | 56,282 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About OLMA
Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) is a stock listed on the Nasdaq Stock Market under the ticker symbol OLMA. It last traded at $7.00 (Oct 30, 2026, 4:00 PM ET), down 4.5% on the day. That gives Olema Pharmaceuticals a market capitalisation of $612.5M.
Over the past 52 weeks OLMA has traded between $6.24 and $36.26.
For the quarter ended Mar 31, 2026 it reported a net loss of $53.1M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$53.1M |
| Dec 31, 2025 | — | -$46.1M |
| Sep 30, 2025 | — | -$42.2M |
| Jun 30, 2025 | — | -$43.8M |
From Olema Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…